Dog Degenerative Joint Disease Multimodal Pain Management

Osteoarthritis in dogs requires a multimodal management approach combining medication, weight management, exercise modification, and rehabilitation.

Key Facts

Osteoarthritis (OA) affects an estimated 20% of dogs over age 1 and 80% of dogs over age 8
OA is a progressive disease causing cartilage degradation, osteophyte formation, and chronic pain
NSAIDs remain the cornerstone of pharmacological management but long-term use requires monitoring
Librela (bedinvetmab), an anti-NGF monoclonal antibody, represents a new monthly injection option with favorable safety profile
Weight loss of 6-8% body weight significantly reduces clinical signs in overweight arthritic dogs
Omega-3 fatty acids, adequan injections, and joint supplements have supportive evidence for adjunctive use
Rehabilitation therapy including hydrotherapy and therapeutic laser improves mobility and reduces pain medication requirements

Welfare Considerations

OA pain in dogs is chronic, often progressive, and frequently underrecognized. Dogs cannot report pain verbally - instead they slow down, stop climbing stairs, or become less playful, changes owners often attribute to normal aging. Multimodal management combining analgesics, weight management, and rehabilitation can dramatically improve quality of life even in advanced OA.

What You Can Do

Use a validated pain assessment tool (Helsinki Chronic Pain Index, LOAD scale) to track your dog comfort over time
Prioritize weight management as the highest-impact non-pharmacological intervention
Ask your vet about Librela as a monthly injection alternative to daily NSAIDs
Implement sloped ramps, orthopedic bedding, and non-slip flooring to reduce joint strain at home
Consult a rehabilitation therapist to develop a home exercise program appropriate for your dog OA stage